Email This Article

This Is No Time to Be Buying Pfizer
By Lissa Morgenthaler
10/22/01 - 07:39 AM EDT
The company's fairly valued already, and at least one of its blockbuster drugs, Lipitor, is looking vulnerable.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,308.26 1,096.07 2,180.05 34.87
Oil *
73.22
DOWN
132.86
DOWN
13.11
DOWN
26.86
DOWN
1.09
10 Yr
3.49%
SPDR Gold
107.34
-1.27%
-1.18%
-1.22%
-3.03%
Data delayed 20 minutes

More From TheStreet

Latest Headlines

Brokerage Partners